Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,774,990 | 5,791,947 | 4,720,566 | 2,973,825 | 1,456,370 |
| Depreciation Amortization | 120,853 | 483,346 | 359,766 | 232,351 | 101,527 |
| Accounts receivable | N/A | 10,481 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -60,912 | N/A | N/A | N/A |
| Other Working Capital | 106,324 | -169,520 | -290,088 | -248,916 | -12,906 |
| Other Operating Activity | -381,711 | 198,077 | 761,244 | 328,338 | 189,862 |
| Operating Cash Flow | $1,620,457 | $6,253,419 | $5,551,488 | $3,285,598 | $1,734,853 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 305,167 | 316,948 | 296,687 | 144,260 |
| PPE Investments | -341,262 | -1,157,022 | -805,168 | -466,329 | -230,014 |
| Net Acquisitions | 60,757 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -6,076 | 1,738 | -5,916 | N/A |
| Sale Of Investment | N/A | 11,089 | -6,320 | 1,627 | N/A |
| Purchase Sale Intangibles | -146,114 | -155,242 | -49,770 | -37,715 | -15,487 |
| Other Investing Activity | -144,463 | -151,293 | -45,662 | -35,644 | -13,480 |
| Investing Cash Flow | $-424,967 | $-998,135 | $-538,464 | $-209,574 | $-99,233 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -715,543 | -2,558,756 | -1,934,394 | -1,183,939 | -608,733 |
| Dividend Paid | -1,949,831 | -2,862,404 | -2,977,352 | -1,693,159 | -1,641,643 |
| Other Financing Activity | 331,355 | 1 | 0 | -1 | 282,211 |
| Financing Cash Flow | $-2,334,019 | $-5,421,159 | $-4,911,746 | $-2,877,099 | $-1,968,165 |
| Exchange Rate Effect | 3,797 | -32,051 | -36,182 | -23,960 | 1,147 |
| Beginning Cash Position | 2,832,786 | 2,804,226 | 2,916,838 | 2,730,382 | 2,647,307 |
| End Cash Position | 1,698,053 | 2,606,300 | 2,981,934 | 2,905,348 | 2,315,910 |
| Net Cash Flow | $-1,134,732 | $-197,926 | $65,096 | $174,966 | $-331,397 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,620,457 | 6,253,419 | 5,551,488 | 3,285,598 | 1,734,853 |
| Capital Expenditure | -342,252 | -1,158,389 | -806,116 | -467,216 | -230,014 |
| Free Cash Flow | 1,278,205 | 5,095,030 | 4,745,372 | 2,818,382 | 1,504,839 |